Integrated Healing Technologies (IHT)
Franklin
About Integrated Healing Technologies (IHT)
Integrated Healing Technologies (IHT) is a technology-enabled wound care services company that specializes in the delivery of negative pressure wound therapy (“NPWT”) devices and systems. Their mission is to accelerate the healing of patients who suffer from acute and chronic wounds. Their experienced management team has collectively founded sixteen healthcare companies that operated facilities and provided services involving medical imaging, ambulatory surgery, mobile imaging, lithotripsy, prostate cancer treatment and independent practice associations. IHT’s superior Negative Pressure Wound Therapy dressing systems promote healing at the wound bed. IHT’s NPWT systems operate at lower pressures, eradicates biofilm, utilize a non-adherent and antimicrobial dressing, inhibit tissue ingrowth and reduce pain associated with higher pressures and dressing changes. Conversely, their competitor’s foam-based system, patented in 1996, applies greater suction pressures above the wound, results in a high bacterial load, promotes tissue ingrowth, typically require pain medication with dressing changes and increases the risk of foam particulate being left in the wound at dressing change. The primary drivers of wound care products and services are diabetes, cardiovascular disease, obesity, an aging U.S. population and Health Care-Associated Infections. Potential customers include: Hospitals, Long Term Care Facilities, Specialty Wound Care Clinics, Nursing Homes, Home Health Care and Durable Medical Equipment (DME) Providers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Last round: Series Unknown (Dec 2017)
- Website: ihtwoundcare.com
- Phone: +1 (877) 572-1999
Industries & Categories
Health Care, Product Design
Social Profiles
Canonical: https://fsome.com/organization/integrated-healing-technologies-iht-136422 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.